• AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 12 Dec 2024 01:21:10   America/Chicago


    AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from Analysts Written by MarketBeat December 12, 2024 Share Link copied to clipboard. AnaptysBio, Inc. ( NASDAQ:ANAB - Get Free Report ) has been given a consensus rec
    Read more...
Share on,